Hisashi Tsukada, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 13 | 2023 | 909 | 1.310 |
Why?
|
| Trachea | 5 | 2012 | 1089 | 1.070 |
Why?
|
| Absorbable Implants | 3 | 2012 | 338 | 0.900 |
Why?
|
| Tracheal Diseases | 2 | 2010 | 118 | 0.660 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2017 | 285 | 0.610 |
Why?
|
| Stents | 5 | 2010 | 3178 | 0.520 |
Why?
|
| Bronchi | 3 | 2022 | 846 | 0.520 |
Why?
|
| Prosthesis Implantation | 2 | 2012 | 591 | 0.510 |
Why?
|
| Aorta, Thoracic | 2 | 2010 | 1096 | 0.450 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 620 | 0.440 |
Why?
|
| Thymectomy | 1 | 2014 | 195 | 0.440 |
Why?
|
| Anemia, Hemolytic | 1 | 2014 | 162 | 0.430 |
Why?
|
| Lung Neoplasms | 9 | 2023 | 13382 | 0.410 |
Why?
|
| Airway Obstruction | 2 | 2022 | 661 | 0.380 |
Why?
|
| Myasthenia Gravis | 1 | 2014 | 214 | 0.380 |
Why?
|
| Drug Delivery Systems | 4 | 2015 | 2222 | 0.350 |
Why?
|
| Paclitaxel | 1 | 2017 | 1730 | 0.350 |
Why?
|
| Catheterization | 1 | 2015 | 1428 | 0.340 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2014 | 664 | 0.330 |
Why?
|
| Pulmonary Atelectasis | 1 | 2010 | 143 | 0.330 |
Why?
|
| Tracheal Stenosis | 2 | 2008 | 228 | 0.330 |
Why?
|
| Guided Tissue Regeneration | 1 | 2010 | 88 | 0.330 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2020 | 739 | 0.320 |
Why?
|
| Silicones | 1 | 2010 | 228 | 0.320 |
Why?
|
| Tracheobronchomalacia | 1 | 2010 | 131 | 0.310 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 311 | 0.290 |
Why?
|
| Pericardium | 2 | 2014 | 664 | 0.270 |
Why?
|
| Tracheostomy | 1 | 2010 | 426 | 0.260 |
Why?
|
| Pneumonectomy | 4 | 2017 | 1119 | 0.260 |
Why?
|
| Bronchial Fistula | 1 | 2005 | 83 | 0.250 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 932 | 0.250 |
Why?
|
| Diaphragm | 1 | 2006 | 351 | 0.230 |
Why?
|
| Polyethylene Terephthalates | 1 | 2004 | 112 | 0.220 |
Why?
|
| Dogs | 4 | 2012 | 3838 | 0.220 |
Why?
|
| Sheep | 3 | 2010 | 1436 | 0.220 |
Why?
|
| Swine | 6 | 2021 | 5907 | 0.200 |
Why?
|
| Prosthesis Design | 4 | 2012 | 2114 | 0.200 |
Why?
|
| Indocyanine Green | 3 | 2020 | 233 | 0.190 |
Why?
|
| Bronchoscopes | 1 | 2021 | 64 | 0.190 |
Why?
|
| Polymers | 1 | 2008 | 1614 | 0.190 |
Why?
|
| Laser Therapy | 1 | 2008 | 1092 | 0.190 |
Why?
|
| Surgical Flaps | 2 | 2008 | 1670 | 0.180 |
Why?
|
| Epinephrine | 2 | 2014 | 792 | 0.180 |
Why?
|
| Computers | 1 | 2022 | 591 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2020 | 5319 | 0.170 |
Why?
|
| Mediastinal Neoplasms | 1 | 2022 | 401 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 18221 | 0.140 |
Why?
|
| Lymphatic Metastasis | 3 | 2020 | 2913 | 0.140 |
Why?
|
| Catheters | 2 | 2017 | 423 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 1269 | 0.140 |
Why?
|
| Injections, Intralesional | 1 | 2017 | 280 | 0.140 |
Why?
|
| Feasibility Studies | 4 | 2022 | 5239 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2008 | 3672 | 0.130 |
Why?
|
| Implants, Experimental | 2 | 2008 | 99 | 0.130 |
Why?
|
| Sarcoma, Kaposi | 1 | 2018 | 374 | 0.120 |
Why?
|
| Anesthesia, General | 1 | 2022 | 1173 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 505 | 0.110 |
Why?
|
| Hemodynamics | 2 | 2015 | 4160 | 0.110 |
Why?
|
| Adrenergic Agonists | 1 | 2013 | 57 | 0.110 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2015 | 197 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2017 | 1635 | 0.110 |
Why?
|
| Animals | 14 | 2021 | 168201 | 0.110 |
Why?
|
| Transplantation, Homologous | 2 | 2010 | 4804 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2017 | 8618 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 654 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15612 | 0.090 |
Why?
|
| Lung | 3 | 2023 | 9998 | 0.080 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 628 | 0.080 |
Why?
|
| Models, Animal | 2 | 2013 | 2109 | 0.080 |
Why?
|
| Surgical Sponges | 1 | 2008 | 39 | 0.080 |
Why?
|
| Polyglactin 910 | 1 | 2008 | 55 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 2018 | 1310 | 0.080 |
Why?
|
| Coronary Circulation | 1 | 2014 | 1569 | 0.080 |
Why?
|
| Omentum | 1 | 2008 | 167 | 0.070 |
Why?
|
| Polyesters | 1 | 2008 | 371 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 20556 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 1 | 2015 | 1086 | 0.070 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 699 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2015 | 2135 | 0.070 |
Why?
|
| Coloring Agents | 2 | 2020 | 562 | 0.070 |
Why?
|
| Titanium | 1 | 2008 | 485 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2010 | 768 | 0.060 |
Why?
|
| Surgical Mesh | 1 | 2008 | 311 | 0.060 |
Why?
|
| Surface Properties | 1 | 2008 | 1161 | 0.060 |
Why?
|
| Infusions, Intravenous | 3 | 2015 | 2214 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2017 | 3461 | 0.060 |
Why?
|
| Materials Testing | 1 | 2008 | 862 | 0.060 |
Why?
|
| Thoracoscopy | 1 | 2005 | 180 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 1288 | 0.060 |
Why?
|
| Genotype | 1 | 2018 | 12978 | 0.050 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 1204 | 0.050 |
Why?
|
| Porosity | 1 | 2004 | 348 | 0.050 |
Why?
|
| Anesthesia | 1 | 2013 | 1591 | 0.050 |
Why?
|
| Male | 10 | 2022 | 360358 | 0.050 |
Why?
|
| Myocardium | 1 | 2014 | 4724 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 3873 | 0.050 |
Why?
|
| Humans | 15 | 2023 | 760617 | 0.040 |
Why?
|
| Biopsy | 2 | 2022 | 6762 | 0.040 |
Why?
|
| Graft Survival | 1 | 2010 | 3820 | 0.040 |
Why?
|
| Pulmonary Veins | 1 | 2005 | 716 | 0.040 |
Why?
|
| Epithelium | 1 | 2004 | 1603 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 1096 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 2014 | 1515 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 39063 | 0.040 |
Why?
|
| Female | 7 | 2022 | 392148 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 1927 | 0.030 |
Why?
|
| Equipment Design | 2 | 2015 | 3501 | 0.030 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2017 | 326 | 0.030 |
Why?
|
| Time Factors | 3 | 2017 | 39913 | 0.030 |
Why?
|
| Poloxamer | 1 | 2014 | 56 | 0.030 |
Why?
|
| Excipients | 1 | 2014 | 98 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 14018 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2015 | 428 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2010 | 64568 | 0.030 |
Why?
|
| Alginates | 1 | 2014 | 248 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2018 | 1118 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2013 | 210 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2021 | 2518 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 2015 | 3796 | 0.030 |
Why?
|
| Heart Rate | 2 | 2014 | 4180 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2017 | 732 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2015 | 1156 | 0.020 |
Why?
|
| Length of Stay | 1 | 2005 | 6418 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 1269 | 0.020 |
Why?
|
| Survival Rate | 1 | 2005 | 12719 | 0.020 |
Why?
|
| Capillaries | 1 | 2014 | 756 | 0.020 |
Why?
|
| Middle Aged | 5 | 2022 | 220584 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4947 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2014 | 2261 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1901 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 4110 | 0.020 |
Why?
|
| Adult | 3 | 2022 | 220969 | 0.020 |
Why?
|
| Aged | 4 | 2022 | 169042 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6807 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4845 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 54360 | 0.020 |
Why?
|
| Prognosis | 1 | 2005 | 29600 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11116 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14648 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15251 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 80566 | 0.010 |
Why?
|
| Heart Failure | 1 | 2015 | 11669 | 0.010 |
Why?
|